Follow The Filings

NTLA

Earnings company data as of 7:50 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by NTLA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NTLA insider trades
  • $1.4M bought by 1 insider
  • None no sales outside a trading plan
  • $1.2M sold by 2 insiders under 10b5-1 plans
  1. John M Leonard CEO
    Planned sale
    $287K 22,675 shares at $12.65 1.9% of stake
    Traded Aug 20–21 Filed Aug 24
  2. Edward J Dulac III CFO
    Planned sale
    $84K 4,677 shares at $18.00 2.9% of stake
    Traded Jul 2 Filed Jul 6
  3. Fred E Cohen Director
    Buy
    $1.4M 150,000 shares at $9.35 +261% to stake
    Traded Jan 5 Filed Jan 7
  4. John M Leonard CEO
    Planned sale
    $836K 88,146 shares at $9.49 7.8% of stake
    Traded Dec 11, 2025 Filed Dec 12, 2025

Also filed in the last 12 months, not counted as buying or selling: 14 stock grants, 12 sales to cover taxes, and 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
8-K 7.01,8.01,9.01
8-K 1.01,2.03,7.01,9.01
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
8-K 7.01,8.01,9.01
8-K 5.07
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
DEF 14A
DEFA14A
8-K 1.01,2.02,9.01
SCHEDULE 13G —
424B5
8-K 7.01,8.01,9.01
424B5
8-K 5.03,9.01
SCHEDULE 13G/A —
8-K 1.01,7.01,8.01,9.01
424B5

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.